Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mersana Therapeutics Inc.

0.3250
-0.0257-7.33%
Post-market: 0.32660.0016+0.49%19:58 EDT
Volume:2.86M
Turnover:954.72K
Market Cap:40.51M
PE:-0.54
High:0.3581
Open:0.3569
Low:0.3233
Close:0.3507
Loading ...
Jul 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 12, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jul 12, 2019

Statement Of Changes In Beneficial Ownership

Initial statement of beneficial ownership of securities
Jun 12, 2019

Major Issues Report

Current report, items 5.02 and 9.01
Jun 11, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 11, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 11, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 11, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 11, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 07, 2019

Major Issues Report

Current report, item 5.07
Jun 05, 2019

Major Issues Report

Current report, items 8.01 and 9.01
May 09, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 09, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Mar 14, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Sep 12, 2018

Correspondence

Jul 16, 2018

Correspondence

Jul 12, 2018

Correspondence